Mother-to-child transmission of HIV-1 in the era prior to the availability of combination antiretroviral therapy: The role of drugs of abuse

Life Sciences

Volumn 88, Issue 21-22, 2011, Pages 922-925

  Van Dyke, Russell B ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Drug use; HIV; Perinatal transmission

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; METHADONE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANNABIS ADDICTION; CD4 LYMPHOCYTE COUNT; CESAREAN SECTION; CHORIOAMNIONITIS; COCAINE DEPENDENCE; COMBINATION CHEMOTHERAPY; DRUG DEPENDENCE; ELECTIVE SURGERY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LOW BIRTH WEIGHT; MACROPHAGE; OPIATE ADDICTION; PATIENT COMPLIANCE; PREGNANT WOMAN; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; REVIEW; TWINS; VAGINAL DELIVERY; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; UNITED STATES; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79956217491     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.03.006     Document Type: Review

References (28)

1. Anon Risk factors for mother-to-child transmission of HIV-1 Lancet 339 8800 1992 1007 1012
2. Y.J. Bryson Perinatal HIV-1 transmission: recent advances and therapeutic interventions AIDS 10 Suppl 3 1996 S33 S42
3. M. Bulterys, S. Landesman, D.N. Burns, A. Rubinstein, and J.J. Goedert Sexual behavior and injection drug use during pregnancy and vertical transmission of HIV-1 J Acquir Immune Defic Syndr Hum Retrovirol 15 1 1997 76 82
4. D.N. Burns, S. Landesman, D.J. Wright, D. Waters, R.M. Mitchell, and A. Rubinstein Influence of other maternal variables on the relationship between maternal virus load and mother-to-infant transmission of human immunodeficiency virus type 1 J Infect Dis 175 5 1997 1206 1210 (Pubitemid 27176512)
5. D.D. Celentano, D. Vlahov, S. Cohn, V.M. Shadle, O. Obasanjo, and R.D. Moore Self-reported antiretroviral therapy in injection drug users JAMA 280 6 1998 544 546
6. I.J. Chasnoff, D.E. Lewis, D.R. Griffith, and S. Willey Cocaine and pregnancy: clinical and toxicological implications for the neonate Clin Chem 35 7 1989 1276 1278 (Pubitemid 19187803)
7. C. Chazotte, J. Youchah, and M.C. Freda Cocaine using during pregnancy and low birth weight: the impact of prenatal care and drug treatment Semin Perinatol 19 4 1995 293 300
8. E.M. Connor, R.S. Sperling, R. Gelber, P. Kiselev, G. Scott, and M.J. O'Sullivan Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group N Engl J Med 331 18 1994 1173 1180 (Pubitemid 24331334)
9. E.R. Cooper, M. Charurat, L. Mofenson, I.C. Hanson, J. Pitt, and C. Diaz Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission J Acquir Immune Defic Syndr 29 5 2002 484 494 (Pubitemid 34456340)
10. A.M. Duliege, C.I. Amos, S. Felton, R.J. Biggar, and J.J. Goedert Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. International Registry of HIV-Exposed Twins J Pediatr 126 4 1995 625 632
11. P.M. Garcia, L.A. Kalish, J. Pitt, H. Minkoff, T.C. Quinn, and S.K. Burchett Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group N Engl J Med 341 6 1999 394 402 (Pubitemid 29362512)
12. C.J. Guo, Y. Li, S. Tian, X. Wang, S.D. Douglas, and W.Z. Ho Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor J Investig Med 50 6 2002 435 442 (Pubitemid 35278684)
13. S.H. Landesman, L.A. Kalish, D.N. Burns, H. Minkoff, H.E. Fox, and C. Zorrilla Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study N Engl J Med 334 25 1996 1617 1623
14. Y. Li, J.D. Merrill, K. Mooney, L. Song, X. Wang, and C.J. Guo Morphine enhances HIV infection of neonatal macrophages Pediatr Res 54 2 2003 282 288 (Pubitemid 36918165)
15. L.S. Magder, L. Mofenson, M.E. Paul, C.D. Zorrilla, W.A. Blattner, and R.E. Tuomala Risk factors for in utero and intrapartum transmission of HIV J Acquir Immune Defic Syndr 38 1 2005 87 95 (Pubitemid 40094125)
16. M.T. McKenna, and X. Hu Recent trends in the incidence and morbidity that are associated with perinatal human immunodeficiency virus infection in the United States Am J Obstet Gynecol 197 3 Suppl 2007 S10 S16
17. L.M. Mofenson, J.S. Lambert, E.R. Stiehm, J. Bethel, W.A. Meyer III, and J. Whitehouse Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team N Engl J Med 341 6 1999 385 393 (Pubitemid 29362511)
18. P. Nair, L. Alger, S. Hines, S. Seiden, R. Hebel, and J.P. Johnson Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women J Acquir Immune Defic Syndr 6 3 1993 298 302 (Pubitemid 23099734)
19. L.S. Robison, A.O. Westfall, M.J. Mugavero, M.C. Kempf, S.R. Cole, and J.J. Allison Short-term discontinuation of HAART regimens more common in vulnerable patient populations AIDS Res Hum Retroviruses 24 11 2008 1347 1355
20. E.M. Rodriguez, L.M. Mofenson, B.H. Chang, K.C. Rich, M.G. Fowler, and V. Smeriglio Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission AIDS 10 3 1996 273 282 (Pubitemid 26093487)
21. D.E. Shapiro, R.S. Sperling, L. Mandelbrot, P. Britto, and B.E. Cunningham Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis. Pediatric AIDS Clinical Trials Group protocol 076 Study Group Obstet Gynecol 94 6 1999 897 908
22. A.D. Steele, E.E. Henderson, and T.J. Rogers Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication Virology 309 1 2003 99 107 (Pubitemid 36506593)
23. G.B. Stefano, B. Scharrer, E.M. Smith, T.K. Hughes Jr., H.I. Magazine, and T.V. Bilfinger Opioid and opiate immunoregulatory processes Crit Rev Immunol 16 2 1996 109 144 (Pubitemid 26303717)
24. S.A. Strathdee, A. Palepu, P.G. Cornelisse, B. Yip, M.V. O'Shaughnessy, and J.S. Montaner Barriers to use of free antiretroviral therapy in injection drug users JAMA 280 6 1998 547 549 (Pubitemid 28377675)
25. K. Tassiopoulos, S. Brogly, P. Brouwers, B. Lester, J. Read, and K. Rich Disclosure of maternal substance use during pregnancy by HIV-infected women Pediatric Academic Societies' Annual Meeting. Baltimore, Maryland 2009
26. B.H. Tess, L.C. Rodrigues, M.L. Newell, D.T. Dunn, and T.D. Lago Breastfeeding, genetic, obstetric and other risk factors associated with mother-to-child transmission of HIV-1 in Sao Paulo State, Brazil. Sao Paulo Collaborative Study for Vertical Transmission of HIV-1 AIDS 12 5 1998 513 520 (Pubitemid 28116161)
27. R.B. Van Dyke, B.T. Korber, E. Popek, C. Macken, S.M. Widmayer, and A. Bardeguez The Ariel Project: a prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy [Erratum appears in J Infect Dis 1999 Mar;179(3):754] J Infect Dis 179 2 1999 319 328 (Pubitemid 29086632)
28. E. Wood, T. Kerr, R. Zhang, S. Guillemi, A. Palepu, and R.S. Hogg Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users HIV Med 9 7 2008 503 507